CD8A and neoplasm: Circular DNA plasmids that encode tumor antigens are used as vaccines and are taken up robustly by antigen-presenting cells (APCs) to activate adaptive immunity through major histocompatibility complex (MHC) class I and II-restricted antigen presentation to CD8+ and CD4+ T cells.22